An asymptomatic young woman was discovered to have life-threatening aneurysms and dissection of the thoracic aorta during routine evaluation in a Turner syndrome (TS) study. The presence of a heart murmur and hypertension had led to diagnosis and surgical repair of an atrial septal defect at age 5 and of aortic coarctation at age 12 years. The diagnosis of TS was made at age 16 year due to short stature and delayed pubertal development. She was treated with growth hormone from age 16–18 year, and with atenolol, thyroid hormone and estrogen. She discontinued her medications and was lost to medical follow-up at age 20 year. On presenting here at age 26 year, she reported a very active lifestyle, including vigorous exercise and an acting career, with no symptoms of chest or back pain or shortness of breath. Cardiovascular imaging revealed aortic regurgitation, an unsuspected dissection of a severely dilated ascending aorta, and a large descending aortic aneurysm. She required surgical replacement of her aortic valve and ascending aorta, followed by endovascular repair of the descending aortic aneurysm. Conclusion: This patient illustrates the importance of considering the diagnosis of TS in girls with congenital aortic defects and the absolute necessity for close, expert follow-up of these patients who are at high risk for complications after surgical repair due to an underlying aortopathy, hypertension and metabolic disorders. This patient also emphasizes the need to publicize and follow screening guidelines as an increasing number of patients with congenital defects transition to adult care.
A 26-year-old woman was evaluated as part of a natural history protocol at the National Institutes of Health (NIH): Turner Syndrome Genotype & Phenotype (NCT00006334). She felt well, worked as a waitress and actress, and exercised 6 day/week with resistance training and running. She had surgical repair of an incomplete atrioventricular canal involving a cleft mitral valve and primum atrial septal defect (ASD) at 5 years of age. She had surgery for aortic coarctation at 12 years of age in 1994. The latter involved bypass of a hypoplastic arch with a 14 mm Dacron Hemashield graft implanted in the ascending aorta proximal to the innominate artery and in the descending aorta just distal to the origin of the left subclavian artery. She tolerated both surgeries well. Persistent arterial hypertension was treated with atenolol.
Turner syndrome (TS) was diagnosed at age 16 year due to short stature (138 cm; <1%) and absent pubertal development. Her karyotype was 45, X. She was treated with growth hormone from age 16–18 year (growing to 156 cm in height), and with estrogen to induce secondary sexual characteristics and menses. Transthoracic echocardiography (TTE) at age twenty year showed mild aortic regurgitation and normal left ventricular function. Shortly thereafter, due to loss of medical insurance, she discontinued estrogen and antihypertensive medications. She had no medical follow-up until she presented as a volunteer for the NIH study.
Physical examination upon admission to the NIH revealed a well developed woman without neck webbing or other features pathognomic of TS. Body weight was 56 kg, height 156 cm and BMI 23 kg/m2. Blood pressure was equal in the upper extremities at 138–140/80 mmHg, and similar in the lower extremities. Heart rate was 74 bpm; oxygen saturation was 100% on room air. She had a high-arched palate and multiple pigmented nevi. There was a well-healed mid-line sternotomy scar. There was a 3/6 systolic ejection murmur heard best at the left upper sternal border radiating to the neck and across the precordium, and a 2/6 moderately long, mid-frequency diastolic murmur heard best along the left mid-lower sternal border. Lungs were clear, abdomen normal and pulses intact, there was no peripheral edema.
A protocol related cardiac magnetic resonance (CMR) scan showed an unsuspected dissection of her dilated ascending aorta (maximal external dimensions 48 × 33 mm), which did not involve the origins of the coronary arteries (
Medical treatment with metoprolol and losartan was initiated, and she underwent surgical repair of the ascending aorta dissection a few days later. The valve was excised and the root was replaced with a mechanical valve conduit in a Bentall fashion. Her vascular tissue was exceptionally friable, even distant from the aneurysm/dissection. Aortic valve pathology showed partial fusion of right and left non-coronary cusps, with severe myxoid degeneration of valve leaflets. Her post-operative course was uneventful and she returned for repair of the descending aortic aneurysm nine months later. Her descending aortic aneurysm was repaired by an endovascular approach.
She has been asymptomatic during 42 months follow-up. CT angiography showed a repaired ascending aortic diameter of 24 mm with significant reduction in the descending aortic aneurysm (area 20 cm2 after fifteen months vs. 25 cm2 postoperatively). CMR at 42 months follow-up confirmed progressive reduction of descending aortic aneurysm size, resolution of a small endovascular leak, and normal function of the prosthetic aortic valve. She has returned to full time work and has married.
Our patient had major congenital cardiovascular issues associated with TS including ASD, aortic coarctation and ongoing hypertension after coarctation repair. Unfortunately, the critical need for life-long follow-up was not recognized by her pediatric caregivers, and she developed life-threatening complications related to TS, including degeneration of her aortic valve associated with aortic regurgitation and dissection of the ascending aorta, and aneurysm formation at the site of graft insertion into the descending aorta
This patient’s story illustrates critical issues related to congenital heart disease in TS. This disorder is due to complete or partial monosomy for the X-chromosome and occurs in ~1/2500 live female births [
This young woman did not have any symptoms related to hypertension, hypothyroidism or her aortic disease. She, her family, and her physicians were unaware of the importance of continued medical treatment and surveillance for potential aortic complications [
This work was supported by the intramural research program of the NIH including 1 Z01 HL004607-08 CE.